{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:04:32Z","timestamp":1794863072392,"version":"4.9.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell&apos;Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca&apos; Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Haematology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/s2352-3026(25)00262-5","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:25:26Z","timestamp":1762313126000},"page":"e908-e917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Von Willebrand factor and von Willebrand disease in ageing: mechanisms, evolving phenotypes, and clinical implications"],"prefix":"10.1016","volume":"12","author":[{"given":"Omid","family":"Seidizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdows","family":"Atiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan T","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parnian","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Castaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lillicrap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2352-3026(25)00262-5_bib1","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.2174\/0929867043364603","article-title":"The hemostatic system","volume":"11","author":"Stassen","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/S2352-3026(25)00262-5_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.critrevonc.2006.06.004","article-title":"Hemostasis and aging","volume":"60","author":"Franchini","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/S2352-3026(25)00262-5_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fcvm.2019.00109","article-title":"Platelet function in aging","volume":"6","author":"Le Blanc","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/S2352-3026(25)00262-5_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41572-024-00536-8","article-title":"von Willebrand disease","volume":"10","author":"Seidizadeh","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S2352-3026(25)00262-5_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1055\/s-2002-36700","article-title":"Aging and thrombosis","volume":"28","author":"Wilkerson","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10184190","article-title":"Age-associated increase in thrombogenicity and its correlation with von Willebrand factor","volume":"10","author":"Alavi","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/S2352-3026(25)00262-5_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/asheducation-2015.1.231","article-title":"Acquired bleeding disorders in the elderly","volume":"2015","author":"Kruse-Jarres","year":"2015","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1016\/S2352-3026(25)00262-5_bib8","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1055\/s-0034-1389079","article-title":"Von Willebrand factor and aging","volume":"40","author":"Konkle","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/hae.13325","article-title":"Can you grow out of von Willebrand disease?","volume":"23","author":"Laffan","year":"2017","journal-title":"Haemophilia"},{"key":"10.1016\/S2352-3026(25)00262-5_bib10","first-page":"39","article-title":"Von Willebrand factor in Italian centenarians","volume":"88","author":"Coppola","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/S2352-3026(25)00262-5_bib11","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1111\/j.1365-2516.2012.02782.x","article-title":"von Willebrand factor: demographics of plasma protein level in a large blood donor cohort from South Wales in the UK","volume":"18","author":"Davies","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/S2352-3026(25)00262-5_bib12","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/jth.13294","article-title":"Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms","volume":"14","author":"Alb\u00e1nez","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.thromres.2020.11.016","article-title":"Rise of levels of von Willebrand factor and factor VIII with age: role of genetic and acquired risk factors","volume":"197","author":"Biguzzi","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/S2352-3026(25)00262-5_bib14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/hae.12664","article-title":"Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease","volume":"21","author":"Rydz","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/S2352-3026(25)00262-5_bib15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ajh.24962","article-title":"Outgrowing the laboratory diagnosis of type 1 von Willebrand disease: a two decade study","volume":"93","author":"Abou-Ismail","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/S2352-3026(25)00262-5_bib16","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.3324\/haematol.2017.168013","article-title":"Increase of von Willebrand factor with aging in type 1 von Willebrand disease: fact or fiction?","volume":"102","author":"Borghi","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/S2352-3026(25)00262-5_bib17","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood-2015-10-673681","article-title":"Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the US","volume":"127","author":"Flood","year":"2016","journal-title":"Blood"},{"key":"10.1016\/S2352-3026(25)00262-5_bib18","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/jth.12586","article-title":"von Willebrand disease and aging: an evolving phenotype","volume":"12","author":"Sanders","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/jth.15116","article-title":"Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease","volume":"19","author":"Biguzzi","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib20","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1182\/blood.2023022457","article-title":"Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies","volume":"143","author":"Atiq","year":"2024","journal-title":"Blood"},{"key":"10.1016\/S2352-3026(25)00262-5_bib21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/jth.15247","article-title":"Von Willebrand disease type 2N: an update","volume":"19","author":"Seidizadeh","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib22","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1161\/STROKEAHA.114.006394","article-title":"Von Willebrand factor drives the association between elevated factor VIII and poor outcomes in patients with ischemic stroke","volume":"45","author":"Samai","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/S2352-3026(25)00262-5_bib23","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCULATIONAHA.109.869156","article-title":"Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) consortium","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/S2352-3026(25)00262-5_bib24","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1538-7836.2011.04333.x","article-title":"von Willebrand factor-to-ADAMTS13 ratio increases with age in a Japanese population","volume":"9","author":"Kokame","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib25","series-title":"Evaluation of the age-related pathophysiology of von Willebrand factor","first-page":"1","author":"Alb\u00e1nez","year":"2015"},{"key":"10.1016\/S2352-3026(25)00262-5_bib26","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1016\/j.jtha.2023.07.023","article-title":"Dynamic and functional linkage between von Willebrand factor and ADAMTS-13 with aging: an atherosclerosis risk in community study","volume":"21","author":"Liu","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MBC.0000000000000065","article-title":"Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis","volume":"25","author":"Stockschlaeder","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/S2352-3026(25)00262-5_bib28","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/ATVBAHA.123.319255","article-title":"Aging is associated with organ-specific alterations in the level and expression pattern of von Willebrand factor","volume":"43","author":"Alavi","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2352-3026(25)00262-5_bib29","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.4228.4228","article-title":"Age-related increases in plasma factor VIII and Von Willebrand factor in a C57BL\/6 mouse model are associated with increased factor VIII and Von Willebrand factor gene expression and reduced expression of the clearance receptor, stabilin-2","volume":"124","author":"Alb\u00e1nez","year":"2014","journal-title":"Blood"},{"key":"10.1016\/S2352-3026(25)00262-5_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrcardio.2013.8","article-title":"The biology behind the atherothrombotic effects of cigarette smoke","volume":"10","author":"Csordas","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2352-3026(25)00262-5_bib31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00431-010-1356-7","article-title":"Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents","volume":"170","author":"Giordano","year":"2011","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2352-3026(25)00262-5_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11357-011-9335-0","article-title":"Increased active von Willebrand factor during disease development in the aging diabetic patient population","volume":"35","author":"Chen","year":"2013","journal-title":"Age"},{"key":"10.1016\/S2352-3026(25)00262-5_bib33","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1182\/blood.V93.12.4277","article-title":"Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter","volume":"93","author":"Keightley","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S2352-3026(25)00262-5_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-4933-2-8","article-title":"Innate immunity and inflammation in ageing: a key for understanding age-related diseases","volume":"2","author":"Licastro","year":"2005","journal-title":"Immun Ageing"},{"key":"10.1016\/S2352-3026(25)00262-5_bib35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.exger.2007.04.008","article-title":"Age-related changes in the hepatic microcirculation in mice","volume":"42","author":"Ito","year":"2007","journal-title":"Exp Gerontol"},{"key":"10.1016\/S2352-3026(25)00262-5_bib36","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4000","article-title":"Cellular senescence in aging and age-related disease: from mechanisms to therapy","volume":"21","author":"Childs","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/S2352-3026(25)00262-5_bib37","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1172\/JCI96400","article-title":"The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity","volume":"128","author":"Swystun","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/S2352-3026(25)00262-5_bib38","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/jth.14521","article-title":"The scavenger receptor SCARA5 is an endocytic receptor for von Willebrand factor expressed by littoral cells in the human spleen","volume":"17","author":"Swystun","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib39","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1182\/blood-2012-10-457507","article-title":"The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels","volume":"121","author":"Rydz","year":"2013","journal-title":"Blood"},{"key":"10.1016\/S2352-3026(25)00262-5_bib40","doi-asserted-by":"crossref","first-page":"13657","DOI":"10.1073\/pnas.1515464112","article-title":"An intrinsic mechanism of secreted protein aging and turnover","volume":"112","author":"Yang","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2352-3026(25)00262-5_bib41","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/jth.14471","article-title":"von Willebrand factor sialylation\u2013a critical regulator of biological function","volume":"17","author":"Ward","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.arr.2012.02.002","article-title":"N-glycomic biomarkers of biological aging and longevity: a link with inflammaging","volume":"12","author":"Dall'Olio","year":"2013","journal-title":"Ageing Res Rev"},{"key":"10.1016\/S2352-3026(25)00262-5_bib43","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00726-010-0773-2","article-title":"Advanced glycation endproducts: from precursors to RAGE: round and round we go","volume":"42","author":"Ramasamy","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/S2352-3026(25)00262-5_bib44","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood.2020005843","article-title":"The relationship between ABO blood group, von Willebrand factor, and primary hemostasis","volume":"136","author":"Ward","year":"2020","journal-title":"Blood"},{"key":"10.1016\/S2352-3026(25)00262-5_bib45","doi-asserted-by":"crossref","first-page":"21238","DOI":"10.1016\/S0021-9258(19)36916-9","article-title":"The interaction of the von Willebrand factor-A1 domain with platelet glycoprotein Ib\/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein","volume":"268","author":"Cruz","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/S2352-3026(25)00262-5_bib46","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1182\/blood-2009-09-241547","article-title":"Expression of terminal alpha2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13","volume":"115","author":"McGrath","year":"2010","journal-title":"Blood"},{"key":"10.1016\/S2352-3026(25)00262-5_bib47","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/blood-2010-02-267450","article-title":"Specific N-linked glycosylation sites modulate synthesis and secretion of von Willebrand factor","volume":"116","author":"McKinnon","year":"2010","journal-title":"Blood"},{"key":"10.1016\/S2352-3026(25)00262-5_bib48","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood.2023021915","article-title":"Novel functions for von Willebrand factor","volume":"144","author":"Atiq","year":"2024","journal-title":"Blood"},{"key":"10.1016\/S2352-3026(25)00262-5_bib49","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/j.1538-7836.2010.03986.x","article-title":"Venous thrombosis in the elderly: incidence, risk factors and risk groups","volume":"8","author":"Engbers","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib50","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0038-1657877","article-title":"Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause","volume":"54","author":"Balleisen","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cardiores.2004.11.013","article-title":"Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly","volume":"66","author":"Yamamoto","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/S2352-3026(25)00262-5_bib52","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/ATVBAHA.117.309918","article-title":"Endothelial cell-derived von Willebrand factor, but not platelet-derived, promotes atherosclerosis in apolipoprotein E-deficient mice","volume":"38","author":"Doddapattar","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2352-3026(25)00262-5_bib53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/S2352-3026(25)00262-5_bib54","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1182\/hematology.2021000288","article-title":"How to manage bleeding disorders in aging patients needing surgery","volume":"2021","author":"Abou-Ismail","year":"2021","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1016\/S2352-3026(25)00262-5_bib55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/hae.13642","article-title":"Cardiovascular disease-related hospitalization and mortality among persons with von Willebrand disease: a nationwide register study in Sweden","volume":"25","author":"Holm","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/S2352-3026(25)00262-5_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12797","article-title":"Lower levels of vWF are associated with lower risk of cardiovascular disease","volume":"6","author":"van Paridon","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib57","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1055\/s-0040-1713636","article-title":"The effect of age on von Willebrand factor and bleeding symptoms in von Willebrand disease","volume":"120","author":"Seaman","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib58","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/1076029617724232","article-title":"The association of aging with von Willebrand factor levels and bleeding risk in type 1 von Willebrand disease","volume":"24","author":"Seaman","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib59","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib60","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jtha.2022.11.045","article-title":"Variability in International Society on Thrombosis and Haemostasis\u2013Scientific and Standardization Committee endorsed Bleeding Assessment Tool (ISTH-BAT) score with normal aging in healthy females: contributory factors and clinical significance","volume":"21","author":"Doherty","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib61","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1182\/bloodadvances.2025016725","article-title":"Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman Program","volume":"9","author":"Atiq","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/S2352-3026(25)00262-5_bib62","first-page":"588","article-title":"von Willebrand disease and angiodysplasia: a wider view of pathogenesis in pursuit of therapy","volume":"110","author":"Crossette-Thambiah","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/S2352-3026(25)00262-5_bib63","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/S2352-3026(25)00262-5_bib64","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.jtha.2025.04.029","article-title":"Genetic study of von Willebrand factor antigen levels \u226450 IU\/dL identifies variants associated with increased risk of von Willebrand disease and bleeding","volume":"23","author":"Friedman","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2352-3026(25)00262-5_bib65","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1182\/hematology.2019000078","article-title":"Evidence-based minireview: perioperative management of the VWD patient at elevated thrombotic risk","volume":"2019","author":"Husseinzadeh","year":"2019","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1016\/S2352-3026(25)00262-5_bib66","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/bloodadvances.2023012348","article-title":"Anticoagulation and antiplatelet agent use among patients with von Willebrand disease and cardiac disease","volume":"8","author":"Merz","year":"2024","journal-title":"Blood Adv"},{"issue":"suppl 6","key":"10.1016\/S2352-3026(25)00262-5_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the management of hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/S2352-3026(25)00262-5_bib68","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2141.2000.02000.x","article-title":"A single nucleotide polymorphism at nucleotide -1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels","volume":"109","author":"Harvey","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/S2352-3026(25)00262-5_bib69","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1182\/blood-2011-01-331074","article-title":"Shear stress-induced unfolding of VWF accelerates oxidation of key methionine residues in the A1A2A3 region","volume":"118","author":"Fu","year":"2011","journal-title":"Blood"}],"container-title":["The Lancet Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352302625002625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352302625002625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T17:45:25Z","timestamp":1766166325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352302625002625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2352302625002625"],"URL":"https:\/\/doi.org\/10.1016\/s2352-3026(25)00262-5","relation":{},"ISSN":["2352-3026"],"issn-type":[{"value":"2352-3026","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Von Willebrand factor and von Willebrand disease in ageing: mechanisms, evolving phenotypes, and clinical implications","name":"articletitle","label":"Article Title"},{"value":"The Lancet Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2352-3026(25)00262-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}